ZA201105477B - Storage stable prostaglandin product - Google Patents

Storage stable prostaglandin product

Info

Publication number
ZA201105477B
ZA201105477B ZA2011/05477A ZA201105477A ZA201105477B ZA 201105477 B ZA201105477 B ZA 201105477B ZA 2011/05477 A ZA2011/05477 A ZA 2011/05477A ZA 201105477 A ZA201105477 A ZA 201105477A ZA 201105477 B ZA201105477 B ZA 201105477B
Authority
ZA
South Africa
Prior art keywords
storage stable
prostaglandin product
stable prostaglandin
product
storage
Prior art date
Application number
ZA2011/05477A
Other languages
English (en)
Inventor
Rajesh Kshirsagar
Sachin Jain
Chandrashekar Kadam
Sm Mudda
Original Assignee
Micro Labs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Micro Labs Ltd filed Critical Micro Labs Ltd
Publication of ZA201105477B publication Critical patent/ZA201105477B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/13Hollow or container type article [e.g., tube, vase, etc.]
    • Y10T428/1352Polymer or resin containing [i.e., natural or synthetic]
    • Y10T428/1397Single layer [continuous layer]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
ZA2011/05477A 2009-02-20 2011-07-25 Storage stable prostaglandin product ZA201105477B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN377CH2009 2009-02-20
PCT/IN2010/000094 WO2010100656A2 (en) 2009-02-20 2010-02-18 Storage stable prostaglandin product

Publications (1)

Publication Number Publication Date
ZA201105477B true ZA201105477B (en) 2012-04-25

Family

ID=42470818

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2011/05477A ZA201105477B (en) 2009-02-20 2011-07-25 Storage stable prostaglandin product

Country Status (10)

Country Link
US (1) US20100216877A1 (pt)
EP (1) EP2398443A2 (pt)
JP (1) JP2012516187A (pt)
AU (1) AU2010220061A1 (pt)
BR (1) BRPI1005519A2 (pt)
CA (1) CA2749352A1 (pt)
MX (1) MX2011008647A (pt)
RU (1) RU2482851C2 (pt)
WO (1) WO2010100656A2 (pt)
ZA (1) ZA201105477B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012038469A2 (en) * 2010-09-21 2012-03-29 S&V Technologies Ag Cosmetic composition
US8951996B2 (en) * 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US8426471B1 (en) * 2011-12-19 2013-04-23 Topokine Therapeutics, Inc. Methods and compositions for reducing body fat and adipocytes
JP5345743B1 (ja) * 2012-02-27 2013-11-20 ロート製薬株式会社 眼科用組成物キット
AU2013351934B2 (en) * 2012-11-30 2018-03-29 Insmed Incorporated Prostacylin compositions and methods for using the same
RU2015134772A (ru) * 2013-03-15 2017-04-21 Аллерган, Инк. Применение биматопроста для повышения выработки лептина
CN104208015A (zh) * 2013-05-29 2014-12-17 天津金耀集团有限公司 含有曲伏前列腺素和防腐剂的眼部制剂
ES2860975T3 (es) 2013-10-25 2021-10-05 Insmed Inc Compuestos de prostaciclina
AU2015349969B2 (en) 2014-11-18 2020-02-06 Insmed Incorporated Methods of manufacturing treprostinil and treprostinil derivative prodrugs
KR101770324B1 (ko) 2016-11-09 2017-08-22 주식회사태준제약 안압 강하용 점안 조성물
US12263119B2 (en) * 2018-07-09 2025-04-01 Zaklady Farmaceutyczne Polpharma S.A. Opthalmic dispensing device
CN114072136B (zh) 2019-04-29 2024-11-29 英斯梅德股份有限公司 曲前列素前药的干粉组合物及其使用方法
KR102756146B1 (ko) 2019-06-28 2025-01-17 한미약품 주식회사 저장 안정성이 개선된 라타노프로스트 함유 점안제
US20220354784A1 (en) * 2021-05-03 2022-11-10 Somerset Therapeutics Llc Stable latanoprost compound ophthalmic compositions
US20220370396A1 (en) * 2021-05-04 2022-11-24 Somerset Therapeutics Llc Methods for modulating conditions of the eye using novel latanoprost compound ophthalmic compositions
WO2025146828A1 (ja) * 2024-01-05 2025-07-10 ロート製薬株式会社 眼科組成物
JP7757564B1 (ja) 2024-06-28 2025-10-21 東亜薬品株式会社 水性組成物
GR1011143B (el) * 2025-04-11 2026-03-02 Ιουλια Τσετη Οφθαλμικο διαλυμα προσταγλανδινης χωρις συντηρητικα

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5716817A (en) * 1980-07-05 1982-01-28 Kaken Pharmaceut Co Ltd Eye drop for adjusting intraocular pressure
US4911920A (en) * 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
JP2594486B2 (ja) * 1991-01-15 1997-03-26 アルコン ラボラトリーズ インコーポレイテッド 局所的眼薬組成物
BR9906597A (pt) * 1998-07-14 2000-07-18 Alcon Lab Inc Produto de prostaglandina
US6235781B1 (en) * 1998-07-14 2001-05-22 Alcon Laboratories, Inc. Prostaglandin product
DK1321144T3 (da) * 2000-09-13 2011-03-07 Santen Pharmaceutical Co Ltd Øjendråber
WO2002022106A2 (en) * 2000-09-14 2002-03-21 Novartis Ag Stable ophthalmic preparation
TW586946B (en) * 2000-12-22 2004-05-11 Novartis Ag Process to improve stability
US20040079671A1 (en) * 2002-08-29 2004-04-29 Paramita Bandyopadhyay Medicinal product packaging
US20050287325A1 (en) * 2004-06-25 2005-12-29 Pharmacia & Upjohn Company Pharmaceutical containers with low adsorption/absorption of active ingredients, and a method of testing materials for adsorption/absorption of active ingredients
JP2006141834A (ja) * 2004-11-24 2006-06-08 Taisei Kako Co Ltd 点眼液を充填するための半透過性容器用ボトル
US20080139648A1 (en) * 2004-12-09 2008-06-12 Santen Pharmaceutical Co., Ltd. Product Containing Prostaglandin Having Fluorine Atom In Its Molecule
US9629852B2 (en) * 2007-10-16 2017-04-25 Sun Pharma Advanced Research Company Ltd. Ophthalmic composition comprising a prostaglandin

Also Published As

Publication number Publication date
JP2012516187A (ja) 2012-07-19
MX2011008647A (es) 2011-10-28
WO2010100656A3 (en) 2010-12-16
BRPI1005519A2 (pt) 2016-02-23
EP2398443A2 (en) 2011-12-28
CA2749352A1 (en) 2010-09-10
AU2010220061A1 (en) 2010-09-10
US20100216877A1 (en) 2010-08-26
WO2010100656A2 (en) 2010-09-10
RU2011133502A (ru) 2013-02-20
RU2482851C2 (ru) 2013-05-27

Similar Documents

Publication Publication Date Title
ZA201105477B (en) Storage stable prostaglandin product
GB2483328B (en) Product
EP2353778B8 (de) Regalmagazin
GB201010595D0 (en) Product
GB0909904D0 (en) Product
GB201002730D0 (en) Product
GB201002508D0 (en) Product
GB0913488D0 (en) Product
EP2570361A4 (en) ARTICLE STORAGE BOX
GB201001395D0 (en) Product
EP2447193A4 (en) STORAGE CONTAINER
GB201116917D0 (en) Storage box
GB201017197D0 (en) Product
GB2469295B (en) Storage case
GB0916978D0 (en) Product
EP2394930A4 (en) STORAGE BOX
GB2467989B (en) Distributed storage
GB0917730D0 (en) Storage furniture
GB2485061B (en) Storage box
TWM390075U (en) Storage box
GB201014211D0 (en) Product
GB201018654D0 (en) Product
GB201019740D0 (en) Product
GB201014324D0 (en) Product
GB201002510D0 (en) Product